296 related articles for article (PubMed ID: 36641897)
1. EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy.
Schmidt MK; Kelly JE; Brédart A; Cameron DA; de Boniface J; Easton DF; Offersen BV; Poulakaki F; Rubio IT; Sardanelli F; Schmutzler R; Spanic T; Weigelt B; Rutgers EJT
Eur J Cancer; 2023 Mar; 181():79-91. PubMed ID: 36641897
[TBL] [Abstract][Full Text] [Related]
2. Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
Hegde JV; Wang X; Attai DJ; DiNome ML; Kusske A; Hoyt AC; Hurvitz SA; Weidhaas JB; Steinberg ML; McCloskey SA
Clin Breast Cancer; 2018 Apr; 18(2):e205-e218. PubMed ID: 29050918
[TBL] [Abstract][Full Text] [Related]
3. Women's preferences for contralateral prophylactic mastectomy: An investigation using protection motivation theory.
Tesson S; Richards I; Porter D; Phillips KA; Rankin N; Musiello T; Marven M; Butow P
Patient Educ Couns; 2016 May; 99(5):814-22. PubMed ID: 27529090
[TBL] [Abstract][Full Text] [Related]
4. Second primary breast cancer after unilateral mastectomy alone or with contralateral prophylactic mastectomy.
Agarwal S; Pappas L; Matsen CB; Agarwal JP
Cancer Med; 2020 Nov; 9(21):8043-8052. PubMed ID: 32918537
[TBL] [Abstract][Full Text] [Related]
5. Contralateral prophylactic mastectomy in an Asian population: a single institution review.
Sim Y; Tan VK; Ho GH; Wong CY; Madhukumar P; Tan BK; Yong WS; Ng YY; Ong KW
Breast; 2014 Feb; 23(1):56-62. PubMed ID: 24275318
[TBL] [Abstract][Full Text] [Related]
6. Women's preferences for contralateral prophylactic mastectomy following unilateral breast cancer: What risk-reduction makes it worthwhile?
Tesson S; Richards I; Porter D; Phillips KA; Rankin N; Costa D; Musiello T; Marven M; Butow P
Breast; 2017 Feb; 31():233-240. PubMed ID: 27969575
[TBL] [Abstract][Full Text] [Related]
7. Trends in Contralateral Prophylactic Mastectomy Utilization for Small Unilateral Breast Cancer.
Baskin AS; Wang T; Bredbeck BC; Sinco BR; Berlin NL; Dossett LA
J Surg Res; 2021 Jun; 262():71-84. PubMed ID: 33548676
[TBL] [Abstract][Full Text] [Related]
8. Contralateral prophylactic mastectomy for unilateral breast cancer in women at average risk: Systematic review of patient reported outcomes.
Srethbhakdi A; Brennan ME; Hamid G; Flitcroft K
Psychooncology; 2020 Jun; 29(6):960-973. PubMed ID: 32201988
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Satisfaction and Body Image After Contralateral Prophylactic Mastectomy.
Anderson C; Islam JY; Elizabeth Hodgson M; Sabatino SA; Rodriguez JL; Lee CN; Sandler DP; Nichols HB
Ann Surg Oncol; 2017 Jun; 24(6):1499-1506. PubMed ID: 28058563
[TBL] [Abstract][Full Text] [Related]
10. Should the use of contralateral prophylactic mastectomy be increasing as it is?
Wood WC
Breast; 2009 Oct; 18 Suppl 3():S93-5. PubMed ID: 19914552
[TBL] [Abstract][Full Text] [Related]
11. Effect of rurality and travel distance on contralateral prophylactic mastectomy for unilateral breast cancer.
Wahlen MM; Lizarraga IM; Kahl AR; Zahnd WE; Eberth JM; Overholser L; Askelson N; Hirschey R; Yeager K; Nash S; Engelbart JM; Charlton ME
Cancer Causes Control; 2023 Dec; 34(Suppl 1):171-186. PubMed ID: 37095280
[TBL] [Abstract][Full Text] [Related]
12. Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.
Wong SM; Freedman RA; Sagara Y; Aydogan F; Barry WT; Golshan M
Ann Surg; 2017 Mar; 265(3):581-589. PubMed ID: 28169929
[TBL] [Abstract][Full Text] [Related]
13. Contralateral Prophylactic Mastectomy for Women with T4 Locally Advanced Breast Cancer.
Murphy BL; Hoskin TL; Boughey JC; Degnim AC; Glazebrook KN; Hieken TJ
Ann Surg Oncol; 2016 Oct; 23(10):3365-70. PubMed ID: 27364506
[TBL] [Abstract][Full Text] [Related]
14. Impact of genetic counseling on the uptake of contralateral prophylactic mastectomy among younger women with breast cancer.
Terkelsen T; Rønning H; Skytte AB
Acta Oncol; 2020 Jan; 59(1):60-65. PubMed ID: 31379231
[No Abstract] [Full Text] [Related]
15. Tools for Contralateral Prophylactic Mastectomy Decision Making.
Gail MH; Jatoi I
J Clin Oncol; 2022 Nov; 40(31):3653-3659. PubMed ID: 35759730
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033).
Davies KR; Brewster AM; Bedrosian I; Parker PA; Crosby MA; Peterson SK; Shen Y; Volk RJ; Cantor SB
Breast Cancer Res; 2016 Sep; 18(1):93. PubMed ID: 27650678
[TBL] [Abstract][Full Text] [Related]
17. Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks.
Boughey JC; Attai DJ; Chen SL; Cody HS; Dietz JR; Feldman SM; Greenberg CC; Kass RB; Landercasper J; Lemaine V; MacNeill F; Song DH; Staley AC; Wilke LG; Willey SC; Yao KA; Margenthaler JA
Ann Surg Oncol; 2016 Oct; 23(10):3100-5. PubMed ID: 27469117
[No Abstract] [Full Text] [Related]
18. Contralateral Prophylactic Mastectomy among Women with Pathogenic Variants in
Makhnoon S; Gutierrez Barrera AM; Bassett R; Afrough A; Bedrosian I; Arun BK
Breast J; 2022; 2022():1447545. PubMed ID: 36685664
[TBL] [Abstract][Full Text] [Related]
19. Contralateral Prophylactic Mastectomy in Patients with Breast Cancer.
Noditi A; Caragheorghe G; Stoleru S; Blidaru A; Bordea CI
Chirurgia (Bucur); 2021; 116(2 Suppl):73-83. PubMed ID: 33963696
[No Abstract] [Full Text] [Related]
20. Trend and survival benefit of contralateral prophylactic mastectomy among men with stage I-III unilateral breast cancer in the USA, 1998-2016.
Yang Y; Pan L; Shao Z
Breast Cancer Res Treat; 2021 Dec; 190(3):503-515. PubMed ID: 34554371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
